1e1x: Difference between revisions

New page: left|200px<br /> <applet load="1e1x" size="450" color="white" frame="true" align="right" spinBox="true" caption="1e1x, resolution 1.85Å" /> '''HUMAN CYCLIN DEPEND...
 
No edit summary
Line 1: Line 1:
[[Image:1e1x.gif|left|200px]]<br />
[[Image:1e1x.gif|left|200px]]<br /><applet load="1e1x" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1e1x" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1e1x, resolution 1.85&Aring;" />
caption="1e1x, resolution 1.85&Aring;" />
'''HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027'''<br />
'''HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027'''<br />


==Overview==
==Overview==
Substituted guanines and pyrimidines were tested as inhibitors of cyclin, B1/CDK1 and cyclin A3/CDK2 and soaked into crystals of monomeric CDK2., O6-Cyclohexylmethylguanine (NU2058) was a competitive inhibitor of CDK1, and CDK2 with respect to ATP (Ki values: CDK1, 5 +/- 1 microM; CDK2, 12, +/- 3 microM) and formed a triplet of hydrogen bonds (i.e., NH-9 to Glu, 81, N-3 to Leu 83, and 2-NH2 to Leu 83). The triplet of hydrogen bonding, and CDK inhibition was reproduced by, 2,6-diamino-4-cyclohexylmethyloxy-5-nitrosopyrimidine (NU6027, Ki values:, CDK1, 2.5 +/- 0.4 microM; CDK2, 1.3 +/- 0.2 microM). Against human tumor, cells, NU2058 and NU6027 were growth inhibitory in vitro (mean GI50 values, of 13 +/- 7 microM and 10 +/- 6 microM, respectively), with a pattern of, sensitivity distinct from flavopiridol and olomoucine. These CDK, inhibition and chemosensitivity data indicate that the distinct mode of, binding of NU2058 and NU6027 has direct consequences for enzyme and cell, growth inhibition.
Substituted guanines and pyrimidines were tested as inhibitors of cyclin B1/CDK1 and cyclin A3/CDK2 and soaked into crystals of monomeric CDK2. O6-Cyclohexylmethylguanine (NU2058) was a competitive inhibitor of CDK1 and CDK2 with respect to ATP (Ki values: CDK1, 5 +/- 1 microM; CDK2, 12 +/- 3 microM) and formed a triplet of hydrogen bonds (i.e., NH-9 to Glu 81, N-3 to Leu 83, and 2-NH2 to Leu 83). The triplet of hydrogen bonding and CDK inhibition was reproduced by 2,6-diamino-4-cyclohexylmethyloxy-5-nitrosopyrimidine (NU6027, Ki values: CDK1, 2.5 +/- 0.4 microM; CDK2, 1.3 +/- 0.2 microM). Against human tumor cells, NU2058 and NU6027 were growth inhibitory in vitro (mean GI50 values of 13 +/- 7 microM and 10 +/- 6 microM, respectively), with a pattern of sensitivity distinct from flavopiridol and olomoucine. These CDK inhibition and chemosensitivity data indicate that the distinct mode of binding of NU2058 and NU6027 has direct consequences for enzyme and cell growth inhibition.


==About this Structure==
==About this Structure==
1E1X is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ACE and NW1 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1E1X OCA].  
1E1X is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ACE:'>ACE</scene> and <scene name='pdbligand=NW1:'>NW1</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1E1X OCA].  


==Reference==
==Reference==
Line 15: Line 14:
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Endicott, J.A.]]
[[Category: Endicott, J A.]]
[[Category: Johnson, L.N.]]
[[Category: Johnson, L N.]]
[[Category: Noble, M.E.M.]]
[[Category: Noble, M E.M.]]
[[Category: ACE]]
[[Category: ACE]]
[[Category: NW1]]
[[Category: NW1]]
Line 27: Line 26:
[[Category: protein kinase]]
[[Category: protein kinase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:38:40 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:22:55 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA